Sorin Group, a developer of medical technologies to treat cardiac rhythm disorders, has purchased Estech cannulae product line that supports minimally invasive and traditional cardiac surgery procedures.
The portfolio of cannulation solutions provides optimal blood flow with the smallest possible size.
The product’s designs allow easy insertion for minimally invasive and traditional cardiac procedures.
Sorin Group Cardiopulmonary Business Unit and Intercontinental president Michel Darnaud said this acquisition further strengthens the company’s position within the cannulae market.
Estech president and CEO John Pavlidis said the company has divested its perfusion product line to focus on minimally invasive cardiac ablation business.